Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (PBYI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PBYI · as of Jun 8, 2026
Key Statistics
Explore Puma Biotechnology, Inc. Data
pbyi stock data · financialsCompetitors & Peers
pbyi competitorsPBYI
ABEO
ALLO
ARCT
AVIR
ELDNAbout Puma Biotechnology, Inc.
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administ…
what is puma biotechnology, inc. · pbyi stock overview · puma biotechnology, inc. company profile · who is puma biotechnology, inc. ceo · pbyi NASDAQ · puma biotechnology, inc. headquarters · puma biotechnology, inc. business segments
About Stock Overview & Key Data
Puma Biotechnology, Inc. (PBYI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 24, 2012. As of the latest trading session, PBYI stock price is $6.85, with a market capitalization of $348.7M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Puma Biotechnology, Inc. (PBYI) stock price is $6.85. The stock is traded on NASDAQ under the ticker symbol PBYI. The 52-week range is $3.03 – $7.90.